HCK and chronic myelogenous leukemia, BCR-ABL1 positive: Pene-Dumitrescu and colleagues showed that HCK overexpression was sufficient to induce imatinib resistance in CML cells, apparently by direct phosphorylation of BCR-ABL1 by HCK29.